ScreenerHero

ANEB Anebulo Pharmaceuticals, Inc.

Partial data
NAS · US · Healthcare · Biotechnology · anebulo.com
0.3000USD-10.18%Mkt Cap: 13.62M $P/E: —

Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing treatments for unintentional cannabis poisoning, acute cannabinoid intoxication, and acute cannabis-induced conditions in the U…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap13.62M USD
Enterprise Value4.21M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-8.48M USD
Revenue/Share—
Last Price0.3000 USD
Fiscal Year EndJun 2025
MR QuarterDec 2025
Employees2
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.50
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B1.68
EPS (TTM)-0.18
EPS (Forward)-0.65
52W Range
0.001010% of range2.850
52W High2.850 USD
52W Low0.0010 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-72.78%
ROA-69.86%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-6.35M USD
CapEx (TTM)—
FCF Margin—
FCF Yield-27.71%
Net Debt-9.04M USD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio6.24
Quick Ratio6.12
Book Value/Sh0.19 USD
Cash/Share0.22 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.40.78M
Float24.13M
Insiders40.84%
Institutions0.00%
Short Interest
Short Ratio1.5d
Short % Float2.20%
Short % Out.0.36%
Shares Short146.37K
Short (prev mo.)58.05K
Technical
SMA 500.3292 (-8.9%)
SMA 2000.6381 (-53.0%)
Beta-1.83
S&P 52W Chg15.96%
Avg Vol (30d)143
Avg Vol (10d)320
Technical Indicators
RSI (14)44.1
MACD-0.0003
MACD Signal0.0022
MACD Hist.-0.0025
BB Upper0.3976 USD
BB Middle0.3387 USD
BB Lower0.2798 USD
BB Width34.76%
ATR (14)0.0553 USD
Vol Ratio (20d)0.77x